Manlunas, Aliyah Zane L.
HRN: 19-00-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2024
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
05/05/2024
05/06/2024
ORAL
2ml
Every 8 Hours
S/P Exlap With Appendectomy
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes